# Protective Effect of EPA on Cardiovascular Events

> **NCT00231738** · PHASE4 · COMPLETED · sponsor: **Kobe University** · enrollment: 18000 (—)

## Conditions studied

- Myocardial Infarction, Unstable Angina Pectoris, Sudden Cardiac Death, Stroke, Peripheral Artery Disease

## Interventions

- **DRUG:** Eicosapentaenoic acid ethyl ester(EPADEL Capsule 300 TM)

## Key facts

- **NCT ID:** NCT00231738
- **Lead sponsor:** Kobe University
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-11
- **Primary completion:** —
- **Final completion:** 2004-11
- **Target enrollment:** 18000 (—)
- **Last updated:** 2015-11-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00231738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00231738, "Protective Effect of EPA on Cardiovascular Events". Retrieved via AI Analytics 2026-09-13 from https://api.ai-analytics.org/clinical/NCT00231738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*